ClearPoint Neuro (CLPT) Set to Announce Quarterly Earnings on Thursday

ClearPoint Neuro (NASDAQ:CLPT - Get Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter. ClearPoint Neuro has set its FY 2024 guidance at EPS.Individual that wish to listen to the company's earnings conference call can do so using this link.

ClearPoint Neuro (NASDAQ:CLPT - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.03. The business had revenue of $7.86 million for the quarter, compared to analyst estimates of $7.50 million. ClearPoint Neuro had a negative net margin of 64.06% and a negative return on equity of 64.23%. During the same quarter last year, the firm earned ($0.29) EPS. On average, analysts expect ClearPoint Neuro to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ClearPoint Neuro Price Performance

CLPT traded down $0.47 during mid-day trading on Thursday, hitting $12.39. The stock had a trading volume of 158,883 shares, compared to its average volume of 183,082. The stock's fifty day simple moving average is $12.09 and its 200-day simple moving average is $8.46. The firm has a market capitalization of $341.91 million, a price-to-earnings ratio of -17.45 and a beta of 1.10. ClearPoint Neuro has a 1-year low of $4.05 and a 1-year high of $14.13.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. B. Riley assumed coverage on ClearPoint Neuro in a report on Thursday, July 25th. They set a "buy" rating and a $10.00 target price on the stock. Lake Street Capital lifted their price objective on ClearPoint Neuro from $11.00 to $15.00 and gave the company a "buy" rating in a report on Tuesday, August 27th.

ClearPoint Neuro Company Profile

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.